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Abstract: Malakoplakia is a rare acquired disease that can affect many systems but is more common in the uro-
genital tract. Cutaneous malakoplakia is even rarer. It is far more frequent in immunodeficient patients. We
report a case of cutaneous malakoplakia in a kidney transplant patient who had recently stopped receiving
immunosuppressive therapy to illustrate a review of the relevant recent literature.
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Resumo: Malacoplaquia é uma doença adquirida rara que pode afetar diversos órgãos e sistemas, mas é mais
comum no trato urogenital. O acometimento cutâneo é ainda menos frequente. Atinge principalmente imunode-
ficientes. Relatamos caso de malacoplaquia cutânea em um paciente transplantado renal que havia recentemen-
te deixado de receber a terapia imunossupressora, a fim de ilustrar uma revisão da literatura recente relevante.
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INTRODUCTION
Malakoplakia is a term derived from the Greek,
meaning “soft plaque”.1,2 The disease was first
described in 1902 by Michaelis and Gutman.3 It
describes a granulomatous process of infectious etiol-
ogy triggered by bacteria that occurs preferentially in
subjects affected by primary or secondary immunode-
ficiency.4,5 The pathogenesis of malakoplakia remains
poorly understood, and it is thought to represent an
acquired bactericidal defect of macrophages associat-
ed with infection, immunosuppression, and/or
immunosuppressive agentes.4.6,7
The most common site of occurrence is the uro-
genital tract, although the condition has also been
found to affect the gastrointestinal and respiratory
tracts, retroperitoneum, thyroid gland, lymph nodes,
bones/joints, middle ear, eyes and brain.4-9 The condi-
tion has been considered rare, and cutaneous malako-
plakia is even rarer; the first case was reported by
Leclerc and Bernier in 1972.10
We report a case of cutaneous malakoplakia in
a kidney transplant recipient and proceed with a
review of the topic.
CASE REPORT
A 51-year-old white man from Brazil, suffering
from idiopathic chronic renal failure, presented with a
2-year history of asymptomatic cutaneous lesion on
the left groin, noticed by his nephrologist during hos-
pitalization due to sepsis caused by catheter infection.
The patient was frequently catheterized at this site
since an unsuccessful kidney transplantation 2 years
before.
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The lesion was a yellow-erythematous-purple
plaque measuring around 1 cm in diameter, on the left
groin, near a femoral vein catheter (Figure 1).
The lesion was sampled for histopathologic and
culture studies. The culture results revealed the
growth of Providentia spp and Candida albicans.
Histopathologic analysis revealed a chronic inflam-
matory process characterized by sheets of closely
packed macrophages containing PAS-positive inclu-
sions (von Hansemann cells)  and calcospherites
known as Michaelis-Gutmann bodies, as demonstrat-
ed by Von Kossa stain, which shows the homoge-
neous bodies in black (Figures 2A, 2B e 2C). Prussian
blue staining demonstrated the presence of hemo-
siderin inside macrophages, which may explain the
purple color of the lesion (Figure 2D).
The patient was treated with surgical excision
in association with sulfametoxazol-trimetoprin antibi-
otic therapy. No evidence of recurrence was detected
on 3-year follow-up, as shown in figure 3.
FIGURE 1:
Malakoplakia:
Picture of the
yellow-erythe-
matous-purple
plaque measu-
ring little more
than 1 cm in
diameter on the
left groin of the
patient near a
femoral vein
cateter
FIGURE 2: Malakoplakia:
A-hematoxylin-eosin
(400 X) stain showing the
sheets of macrophages.
B-von Hansemann cells
in PAS stain (400 X)(black
arrow). C-Michaelis-
Gutmann bodies, shown
in black after Von Kossa
staining (400 X)(black
arrow). D-Prussian blue
demonstrates hemoside-
rin inside macrophages
(400 X)
FIGURE 3:
Malakoplakia: Left
groin picture of
the same patient
after treatment
and 3-year follow-
up
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DISCUSSION
Malakoplakia is a rare granulomatous disease
in which a defect of the killing capacity of
macrophages after endocytosis is considered to be the
central event. Disturbed phagosome-lysosome fusion
was suggested, but it is still not clear how and why
this disorder happens, and the hypothesis is not fully
accepted.11-13 We reviewed published articles in
indexed periodicals that appeared in a PubMed search
performed using the term “cutaneous malakoplakia”.
Based on Kohl et al. 2008, we added cases of cutaneous
malakoplakia published from January 2006 until
January 2012, as demonstrated in chart 1.14
While the majority of subjects are immunodefi-
cient patients, including HIV-infected patients,
patients with neoplasia, transplanted patients and
others, more recently cases involving previously
healthy patients have been reported.15-17 Almost all
transplanted patient cases refer to kidney recipients,
as the one in this article, but two were reported in
heart transplant recipients.18,19 There are few reports in
which prevalence among women is higher (2:1).20,21
The age peak occurs between the sixth and seventh
decades, being even rarer in children.17,22
Approximately 90% of patients have coliform
bacteria detected in urine, blood, or tissue, suggesting
an infectious cause.4 The most commonly found bac-
terium is Escherichia coli, but Klebsiella, Proteus,
Pseudomonas, Mycobacterium avium, Mycobacterium
tuberculosis, Shigella, Staphylococcus aureus and
Enterococcus spp were also found.23,24 Rhodococcus equi
is the most commonly implicated microbe in HIV-
infected patients.25 In 75% of cases, the disease affects
the genitourinary tract, but other systems have been
implicated, including the skin.26
No typical clinical presentation is described,
skin  presentation varies from papules, plaques, nod-
ules, abscesses with or without fluctuation, and fistu-
la to ulcers, cystic and polypoid masses.14 Therefore,
the diagnosis is predominantly confirmed by anato-
mopathologic and culture studies. Vanbrabant et
al.2004 recently described the possibility of using 18-
fluoro-deoxyglucose positron emission tomography
for diagnosis and follow-up.27
Histopathologically, the pathognomonic find-
ing of Michaelis-Gutmann bodies, which represent
partially degraded bacterial organisms, can establish
the diagnosis. Michaelis-Gutmann bodies are intracy-
toplasmic, round-ovoid, basophilic, concentric lami-
nated inclusions in macrophages that are typically
enlarged and display foamy cytoplasm and eccentric,
hyperchromatic, round nuclei, denoted as
Hansemann cells.
Differential diagnosis is possible with other
infectious diseases or neoplastic and reactive/repara-
tive processes. Infections to consider include tubercu-
losis, Whipple’s disease, lepromatous leprosy, fungus
(Cryptococcus), and parasites (leishmaniasis). Special
stains for microorganisms and tissue culture are nec-
essary. Reactive and neoplastic processes include
Langerhans cell histiocytosis, fibrous histiocytoma,
lymphoma, granular cell tumor, xanthoma, foreign-
body granuloma, hemophagocytic syndromes, and
sarcoidosis.14 Although generally presenting benign
self-limited evolution, a fatal outcome is possible, but
none was described in cutaneous malakoplakia.28
Pseudomalakoplakia was once described as a prolifer-
ation of histiocytes at a previous surgical site, but only
as an abstract. No other publications on this theme are
found.29
Our observation that the disease developed on
a site of recognized trauma and contamination, in
accordance with other related cases, highlights the
importance of direct inoculation of bacteria in the
pathophysiology, since the presence of immunosup-
pression is necessary, but not sufficient for its develop-
ment.
There are no prospective comparative studies,
probably due to the limited incidence, so approaches
to management vary from surgical excision, with or
without antibiotics, to the use of antibiotics alone.8
Van der Voort et al. 1996 compared treatments and
concluded that surgical excision achieved the higher
cure rate (90%), and that, when comparing antibiotics,
quinolones seemed to be superior.7 The discontinua-
tion of immunosuppressives and treatment of HIV
could also be helpful.7,9 Sulfamethoxazole-trimetho-
prim is also cited as effective.30 It was selected by us
due to considerations such as cost, access and drug
interaction.
We illustrated this article reporting a case of
cutaneous malakoplakia synchronous to previous
immunosuppressive therapy, in a subject with no cur-
rent immunosuppressive treatment. The option for
surgical plus antibiotic treatment resulted in cure with
no recurrence to date. We also reviewed the literature
and counted the reported cases of cutaneous malako-
plakia described on chart 1 (including this one).31-66 ❑
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Case Reference Age/Sex Location Gross Medical History
No. No.
1 5 51 y/M Perianal, inguinal, scrotum Nodules and ulcerations Kidney Tx 
2 5 67 y/M Right temple Nodule Kidney Tx 
3 33 69 y/F Right axilla Ulceration and mass RA, breast carcinoma 
4 34 40 y/F Inguinal, broad ligament Ulceration N/A 
5 10 64 y/M Perianal Indurated mass RA 
6 35 35 y/M Left eyelid Nodule Kidney Tx 
7 1 64 y/M Perianal Ulceration Lymphoma 
8 36 75 y/F Vulva Ulceration RA 
9 37 50 y/F Abdominal wound Polypoid mass N/A 
10 38 31 y/M Right axilla Mass HIV 
11 9 32 y/M Abdomen Abdomen Abscess Kidney Tx 
12 9 44 y/M Perianal and left lung Abscess Kidney Tx 
13 9 42 y/M Right axilla Chronic abscess SLE 
14 39 70 y/M Buttock Nodule Chronic hepatitis  C 
15 40 75 y/M Right hand and wrist Abscess N/A 
16 41 41 y/M Peritoneal, supraclavicular Cystic mass and firm nodule DM 
17 42 74 y/M Perianal Nonhealing lesion MPD 
18 43 55 y/M Gluteal cleft Ulcers HIV 
19 44 67 y/M Left neck Mass No significant PMH 
20 45 81 y/F Frontal mass Irregular plaque DM 
21 46 56 y/M Internal canthus of eye Nodule Sarcoidosis 
22 32 44 y/F Buttock Nodule Kidney Tx 
23 47 60 y/F Nasolabial  sulcus Ulceration N/A 
24 14 2 mo/M Colorectal and perianal Polypoid masses Immunodeficiency 
25 2 68 y/M Left inguinal region Papules N/A 
26 2 66 y/M Right axilla Nodule RA, DM 
27 48 53 y/F Perineum Papules Kidney Tx 
28 49 42 y/M Inguinal region Mass  with ulceration Lymphoma 
29 50 41 y/M Frontal scalp, right lung Abscess, pulmonary  lesions HIV, Hepatitis B 
30 51 64 y/F Left neck mass Mass  with cavitation Thyroidectomy 
31 52 60 y/M Gluteal fold Cutaneous  fistula DM 
32 53 62 y/M Chest Ulceration N/A 
33 54 65 y/M Ureterocutaneous  fistula Abdominal fistula N/A 
34 19 51 y/M Perianal Nodule Heart Tx 
35 55 69 y/M Left arm and flank Ulceration, mass Escherichia coli sepsis
36 56 55 y/F Abdominal  wall Papules N/A 
37 57 22 y/F Arm Fluctuating mass N/A 
38 58 52 y/F Inferior abdomen Fistula  with abscess Kidney Tx 
39 59 30 y/M Perianal Abscesses Dermatomyositis 
40 60 51 y/M Left thigh Mass  with draining abscess HIV, DM 
41 16 60 y/F Abdominal  fold Pink-yellow plaques Healthy
42 17 23 y/M Perianal Pink nodules Healthy
43 18 14 Y/M Gluteal  fold Papule Healthy
44 20 55 y/F Right Labia "Boil" (nodule + abscess) Heart Tx
45 27 58 y/M Perianal Erosive plaque Psoriasis
46 61 63 y/F Abdominal  wall Fistula Pulmonary sarcoidosis
47 62 83 y/F Neck Goma (nodule + fistula) SLE, RA, Sjogren
48 63 45 y/F Perigenital Papules, nodules and sinuses HIV
49 64 24 y/M Abdominal  wall Fistula Psoas  abscess (Tuberculosis?)
50 65 87 y/M Buttock Scaly  plaques  and  polypoid nodules No significant PMH 
51 66 66 y/M Lower abdomen Abscesses, nodules and fistula Poor overall  health
52 current 51 y/M Left groin Plaque Kidney Tx
article case
Reported Cases of Cutaneous Malakoplakia in the Literature*
CHART 1: Reported cases of cutaneous Malakoplakia
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